The FDA has approved the first treatment for children with Menkes disease, a rare and often severe genetic disorder that starts in infancy. The bigger story is how quickly the disease can cause harm — and why faster diagnosis may matter as much as treatment itself.
CDC and ACOG say families now have two main ways to protect babies from RSV: maternal vaccination during the right pregnancy window or an antibody product for the infant. New CDC surveillance suggests many babies still miss protection, often when clinicians do not clearly recommend it.
A March 2026 heart guideline says adults should have lipoprotein(a), or Lp(a), measured at least once as part of cardiovascular risk assessment. That does not mean everyone needs urgent testing, but it does give many adults a reason to ask whether this separate blood test has ever been done.
ACOG’s April 23, 2026 update backs patient-collected high-risk HPV screening as an option for some average-risk adults ages 30 to 65. Here’s who it may fit, what it does not replace, how follow-up works, and when most insurance coverage is expected to change.
The FDA says it has started two proof-of-concept clinical trials that will send some endpoints and data signals to the agency in real time. The agency is also asking for input on a pilot program that could begin this summer. For readers, the big question is not whether trial oversight is changing today, but whether this early test can improve safety monitoring without adding confusion or weakening transparency.
The FDA has reminded more than 2,200 sponsors and researchers to submit overdue clinical trial results. For patients and clinicians, the issue is not just paperwork: missing results can leave the public record incomplete and make it harder to judge how well a treatment worked, or how safe it looked.
CDC’s latest early data suggest this season’s flu shots offered moderate protection, especially against severe illness, but not complete protection. Flu activity is easing, yet hospitalizations remain high, so vaccination and basic prevention still matter as the season continues.
CMS issued a new interim final rule on June 1, 2026, setting a January 1, 2027 start for Medicaid community-engagement requirements in many states. The policy could affect some adults ages 19 to 64 and may create paperwork and renewal hurdles that vary by state.
Federal health officials say a multistate Salmonella outbreak is tied to recalled moringa supplement products. Here’s what was recalled, who may be at higher risk, and what to do if the products are in your home.
The basic vaccine-coverage framework in the U.S. still starts with CDC immunization schedules and the rules of your insurance plan. But in 2026, readers may find no-cost coverage harder to interpret because eligibility can differ by age, plan type, and public program. Here is a plain-language guide to what is usually covered, where gaps can appear, and what families, adults, and caregivers should check before booking an appointment.
If you use a TRUE METRIX blood glucose meter, the FDA says to keep testing but switch to another glucose-testing method as soon as you can. The concern is an E-5 error code that can mean either a very high blood sugar reading or a strip problem, which could delay treatment or lead to the wrong response.
The FDA has updated the meaning of “healthy” on food packages, and the new standard is meant to line up better with current nutrition science. The label can still be a helpful shortcut, but it is not a guarantee that a food is the best choice for every shopper.
Hospitals must now meet updated federal price-transparency requirements that took effect in 2026, but the numbers still won’t tell every patient what they will owe. Here’s how the new files and shoppable-service displays can help — and where the limits remain.
The FDA says one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream was recalled because it was contaminated with Staphylococcus aureus. If you use eczema cream or another topical product at home, it is worth checking the label, lot number, and expiration date before you apply it again. Here’s how to tell whether a cream in your medicine cabinet is affected, what contamination can mean for irritated skin, and when skin symptoms should prompt a call to a clinician.
Measles remains a live public-health issue in the U.S. because CDC has reported ongoing outbreaks and updated its 2026 guidance on vaccination and post-exposure steps. For most people, the key move is simple: check your MMR records now and act fast if public health officials tell you you were exposed.
A quick look at the Nutrition Facts label can tell you whether a packaged food is low or high in added sugars. The key is to compare the grams, the % Daily Value, and the serving size.
CMS has launched a $50 billion Rural Health Transformation Program and begun moving it into implementation. The program is designed to help states test ways to improve rural access, workforce supply, technology, and chronic disease care, but it is not a quick fix for deeper hospital-finance and Medicaid pressures.
The FDA is pushing medical AI toward more transparent testing and stronger follow-up after a device reaches real-world care. That matters because AI tools can behave differently once they are used in busy clinics, with different patients, workflows, and data than they saw during development. For patients and families, the key question is not whether AI is present, but whether it is a regulated medical device, how it was evaluated, and what happens if its performance changes over time.
Federal guidance now gives women ages 30 to 65 at average risk a new option for cervical cancer screening: collecting the sample themselves for high-risk HPV testing. The change may make screening easier to access, but it is not treatment, and a positive result still needs follow-up care.
Hospitals now face updated federal price-transparency requirements that CMS began enforcing on April 1, 2026. The goal is to make posted hospital prices more standardized and easier to compare, but the numbers still won’t equal your final bill.
Sun Pharmaceutical Industries is recalling one batch of doxorubicin hydrochloride liposome injection in the United States after the FDA said some vials may contain glass particles. Patients, caregivers, hospitals, infusion centers, and pharmacists should check lot numbers and contact the care team if the product may have been used.
CDC says 2026 measles cases are still climbing, and most are tied to outbreaks. Here’s what the latest data means for families, schools, workplaces, and communities—and why vaccination coverage still matters.
End of content
End of content
